AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 TrialSakib Burza, Krishna Pandey, Neena Verma et al.|Clinical Infectious Diseases|2022Cited by 53
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, IndiaVishal Goyal, Fabiana Alves, Vidya Nand Rabi Das et al.|PLoS neglected tropical diseases|2020Cited by 37
Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, IndiaVishal Goyal, Jorge Alvar, Raman Mahajan et al.|PLoS neglected tropical diseases|2018Cited by 25
Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, IndiaVishal Goyal, Jorge Alvar, Sakib Burza et al.|PLoS neglected tropical diseases|2019Cited by 15
A Randomized Trial of AmBisome Monotherapy and Combination of AmBisome and Miltefosine for the Treatment of Visceral Leishmaniasis in HIV-Positive Patients in IndiaSakib Burza, Pradeep Das, Krishna Pandey et al.|Unknown|2019Cited by 1